The majority of those deals involved the hospital sector, followed in descending order by long-term care, behavioral healthcare, home healthcare, biotechnology and other services.
During the five-and-a-half-year period covered in the report, hospital systems and pharmaceutical products were the targets in the majority of the largest deals that involved the sale of a non-profit healthcare organization or asset, according to the report.
Here are the top nine healthcare transaction deals based on dollar value from Jan. 1, 2007 to June 30, 2012 where a non-profit was targeted:
1. Vanguard Health Systems in Nashville, Tenn., acquired Detroit Medical Center in 2010 for $1.22 billion.
2. Cerberus Capital Management, a private equity firm in New York City, acquired Boston-based Caritas Christi Health Care in 2010 for $830 million before renaming it Steward Health Care System.
3. Royalty Pharma AG in New York City acquired royalty interest in Lyrica, a drug used to relieve neuropathic pain, in 2007 for $700 million from Northwestern University in Evanston, Ill.
4. Royalty Pharma AG acquired royalty interest in Remicade, a biologic drug used to reduce symptoms of rheumatoid arthritis, in 2007 for $650 million from New York University.
5. Ascension Health in St. Louis acquired Alexian Brothers Health System in Arlington Heights, Ill., in 2011 for $645 million.
6. Health Management Associates in Naples, Fla., acquired Mercy Health Partners in Toledo, Ohio, a subsidiary of Catholic Health Partners in Cincinnati in 2011 for $532.4 million.
7. Trinity Health in Novi, Mich., acquired Loyola University Health System in Maywood, Ill., in 2011 for $475 million.
8. Adventist Health Systems in Altamonte Springs, Fla., acquired University Community Health in Tampa Bay, Fla., in 2010 for $355 million.
9. Banner Health in Phoenix acquired Sun Health Corp. in Sun City, Ariz., in 2007 for $316 million.
Correction: An earlier version of this article included 10 healthcare transactions. However, the tenth transaction listed, between Pittsburgh-based Highmark and Pittsburgh-based West Penn Allegheny Health System, is currently under litigation. In addition, the total deal value was incorrect. The West Penn Allegheny Health and Highmark deal would be worth $475 million if it were to finalize.
More Articles on Healthcare Transaction Activity:
Healthcare M&A Deal, Dollar Volume Dives in 3Q
Healthcare IT Funding, M&A Strong in 3Q With 74 Deals Worth $3.4B
M&A Volume in Healthcare IT Market Rises 19% in 3Q
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
